NEW YORK (GenomeWeb News) – Danaher today said that revenues in the fourth quarter rose nearly 6 percent year over year paced by its Life Sciences and Diagnostics segment.

For the three months ended Dec. 31, 2012, the company posted total revenues of $4.98 billion, up from $4.72 billion in the year-ago period, and beating the consensus Wall Street estimate of $4.81 billion.

Core revenues increased 3.5 percent year over year during the quarter, while acquisitions added 3 percent growth, and the impact of currency translation cut growth by 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.